Individual Patient Expanded Access to CA102N

ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line

NCT02624895 ·Status: COMPLETED

A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer

NCT05846867 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

NCT06490913 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

LEAC-102 for Advanced Colorectal Cancer

NCT02826837 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

NCT06826092 ·Status: RECRUITING ·Phase: PHASE2

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer

NCT05382442 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen

NCT04680104 ·Status: COMPLETED

FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

NCT02935764 ·Status: UNKNOWN ·Phase: PHASE3

Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

NCT01046864 ·Status: COMPLETED ·Phase: PHASE1

Study of Perifosine + Capecitabine for Colon Cancer Patients

NCT01048580 ·Status: COMPLETED ·Phase: PHASE1

A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

NCT01269216 ·Status: COMPLETED ·Phase: PHASE2

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

NCT03014297 ·Status: TERMINATED ·Phase: PHASE1

NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

NCT00675012 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer

NCT00001428 ·Status: COMPLETED ·Phase: PHASE2

FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer

NCT00501410 ·Status: COMPLETED ·Phase: PHASE1

AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer

NCT07021950 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer

NCT04446793 ·Status: NO_LONGER_AVAILABLE

TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC

NCT03517618 ·Status: COMPLETED ·Phase: PHASE2

Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer

NCT00921661 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

NCT02482441 ·Status: COMPLETED ·Phase: PHASE1

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

NCT01840280 ·Status: COMPLETED

A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer

NCT01326000 ·Status: COMPLETED ·Phase: PHASE2

Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer

NCT00209625 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

NCT00507091 ·Status: COMPLETED ·Phase: PHASE1

mFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon Cancer

NCT06890624 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2